TABLE OF CONTENTSOsi Pharmaceuticals Inc • April 22nd, 2005 • In vitro & in vivo diagnostic substances • England and Wales
DEED OF SHARE EXCHANGE THIS DEED is made the day of 2005 BETWEEN: (1) OSI PHARMACEUTICALS, INC., a company incorporated under the laws of the state of Delaware, USA and having its registered office at 58 South Service Road, Melville, New York, 11747, USA (the "PARENT COMPANY"); and (2) 'First-Name' 'Surname' of 'Address-1', 'Address-2', 'Address-3', 'Address-4' 'Address-5' (the "MEMBER"), each a "PARTY" and collectively the "PARTIES"). RECITALS: (A) WHEREAS Prosidion Limited was incorporated under the laws of England and Wales on 25 November 2002 (registered number 4600121) and has an authorised share capital of 2,000 Pound divided into 14,000,000 Preferred Ordinary Shares of 0.0001 Pound each ("PREFERRED ORDINARY SHARES"); 4,000,000 A Ordinary Shares of 0.0001 Pound each ("A ORDINARY SHARES"); and 2,000,000 B Ordinary Shares of 0.0001 Pound("B ORDINARY SHARES") each. (B) WHEREAS 'Shareholding' B Ordinary Shares (the "SHARES") have been issued to the Member. (C) WHEREAS the Member is t
TABLE OF CONTENTSOsi Pharmaceuticals Inc • April 22nd, 2005 • In vitro & in vivo diagnostic substances • England and Wales
DEED OF SHARE EXCHANGE THIS DEED is made the day of 2005 BETWEEN: (1) OSI PHARMACEUTICALS, INC., a company incorporated under the laws of the state of Delaware, USA and having its registered office at 58 South Service Road, Melville, New York, 11747, USA (the "PARENT COMPANY"); and (2) 'FIRST-NAME' 'SURNAME' of 'Address-1', 'Address-2', 'Address-3', 'Address-4' 'Address-5' (the "MEMBER"), (each a "PARTY" and collectively the "PARTIES"). RECITALS: (A) WHEREAS Prosidion Limited was incorporated under the laws of England and Wales on 25 November 2002 (registered number 4600121) and has an authorised share capital of 2,000 pound divided into 14,000,000 Preferred Ordinary Shares of 0.0001 Pound each ("PREFERRED ORDINARY SHARES"); 4,000,000 A Ordinary Shares of 0.0001 Pound each ("A ORDINARY SHARES"); and 2,000,000 B Ordinary Shares of 0.0001 ("B ORDINARY SHARES") each. (B) WHEREAS 'FounderIIBIIShares' B Ordinary Shares (the "SHARES") have been issued and allotted to the Member. (C) WHEREAS
